Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma

被引:57
作者
Andersen Y.M.F. [1 ]
Egeberg A. [1 ]
Skov L. [1 ]
Thyssen J.P. [1 ]
机构
[1] Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Kildegårdsvej 28, Hellerup
关键词
Atopic dermatitis; Autoimmune disease; Cancer; Cardiovascular disease; Comorbidities; Neuropsychiatric disease;
D O I
10.1007/s13671-017-0168-7
中图分类号
学科分类号
摘要
Purpose of Review: In this review article, we summarize the current evidence about atopic dermatitis (AD)-associated comorbidities, beyond the traditional atopic and allergic conditions. Recent Findings: Patients with AD may have an increased risk of cardiovascular diseases, certain malignancies, autoimmune diseases, and neuropsychiatric diseases. The causes of these associations are likely multifactorial and may include genetic predispositions, systemic low-grade inflammation, environmental exposures, medication, and lifestyle and behavioral risk factors. There appears to be geographical variations in prevalence of comorbidities in patients with AD, indicating that differences in ethnicity and lifestyle factors may significantly influence the risk of certain comorbidities. Summary: The reported comorbidities in recent literature emphasize the burden of disease in patients with AD. Early appropriate AD therapy, in combination with reduction of risk factors, may help prevention of certain comorbidities. The reported observations may generate hypotheses for future investigations in underlying risk factors for AD-associated comorbidities. © 2017, Springer Science+Business Media New York.
引用
收藏
页码:35 / 41
页数:6
相关论文
共 96 条
[1]  
Taylor B., Wadsworth M., Wadsworth J., Peckham C., Changes in the reported prevalence of childhood eczema since the 1939-45 war, Lancet, 324, pp. 1255-1257, (1984)
[2]  
Deckers I.A.G., McLean S., Linssen S., Mommers M., van Schayck C.P., Sheikh A., Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies, PLoS One, 7, (2012)
[3]  
Weidinger S., Novak N., Atopic dermatitis, Lancet, 387, pp. 1109-1122, (2016)
[4]  
Henriksen L., Simonsen J., Haerskjold A., Linder M., Kieler H., Thomsen S.F., Stensballe L.G., Incidence rates of atopic dermatitis, asthma, and allergic rhinoconjunctivitis in Danish and Swedish children, J Allergy Clin Immunol, 136, pp. 360-366.e2, (2015)
[5]  
Williams H., Stewart A., von Mutius E., Cookson W., Anderson H.R., Is eczema really on the increase worldwide?, J Allergy Clin Immunol, 121, pp. 947-954, (2008)
[6]  
Kim J.P., Chao L.X., Simpson E.L., Silverberg J.I., Persistence of atopic dermatitis (AD): a systematic review and meta-analysis, J Am Acad Dermatol, 75, pp. 681-687.e11, (2016)
[7]  
Margolis J.S., Abuabara K., Bilker W., Hoffstad O., Margolis D.J., Persistence of mild to moderate atopic dermatitis, JAMA dermatology, 150, pp. 593-600, (2014)
[8]  
Zheng T., Oh M., Zhu Z., The atopic march: progression from atopic dermatits to allergic rhinitis and asthma, Allergy Asthma Immunol Res, 3, pp. 67-73, (2011)
[9]  
Zhang A., Silverberg J.I., Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis, J Am Acad Dermatol, 72, pp. 606-616, (2015)
[10]  
Silverberg J.I., Greenland P., Eczema and cardiovascular risk factors in 2 US adult population studies, J Allergy Clin Immunol, 135, pp. 721-728.e6, (2015)